Company Search:
Advanced Search
Sponsored Links
Rexahn Pharmaceuticals Inc. Company Snapshot
Rexahn Pharmaceuticals Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Rexahn Pharmaceuticals Inc. with three other companies in this sector in UNITED STATES : Mannkind Corporation (2010 sales of $93,000.00 of which 100% was Therapeutic Products), Myrexis Inc ($90,000.00 of which 100% was Pharmaceutical), and Stromacel Inc ($83,321.00 of which 100% was Sperm Bank).

Sales Analysis. Rexahn Pharmaceuticals Inc. reported sales of $75,000.00 for the year ending December of 2010. This represents a very small increase of 0.0% versus 2009, when the company's sales were $75,000.00 . The sales level in 2010 was fairly close to the level five years ago: in 2005, Rexahn Pharmaceuticals Inc. had sales of $75,000.00 .
  Stock Performance Chart for Rexahn Pharmaceuticals Inc.
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 2.31
(Figures in U.S. Dollars)
1 Week 26.2%   13 Weeks -8.0%  
4 Weeks -22.5%   52 Weeks 4.5%  
Rexahn Pharmaceuticals Inc. Key Data:
  Ticker: REXN Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2010 Sales 75,000
(Year Ending Jan 2011).
Employees: 5
  Currency: U.S. Dollars Market Cap: 9,284,216
  Fiscal Yr Ends: December Shares Outstanding: 4,019,141
  Share Type: Common Closely Held Shares: 9,938
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.